Intravitreal Administration of Ranibizumab for Idiopathic Choroidal Neovascularization in a Pregnant Woman

Authors:

Abstract
Idiopathic choroidal neovascularization (ICNV) is a rare form of choroidal neovascularization (CNV) affecting patients of working age (age ≤ 50 years) and having a significant impact on visual acuity (VA) and quality of life [1]. The occurrence of ICNV in pregnancy is very rare and has been reported in the literature only twice [2] [3]. Treatment of ICNV with ranibizumab and bevacizumab has been reported in small case series [3] [4] [5]. We report a case of subfoveal ICNV and its treatment with intravitreal ranibizumab in a healthy, young woman during the third trimester of pregnancy.